Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ENTBF - Entheon Biomedical gets recruitment underway in EBIQ-101 ketamine study

ENTBF - Entheon Biomedical gets recruitment underway in EBIQ-101 ketamine study

Entheon Biomedical Corp Com
Entheon Biomedical (OTCQB:ENTBF) announces that recruitment has begun for the clinical research study with Heading Health to determine the electro-neurophysiologic effects of ketamine. EBIQ-101, an Open Label Observational Study, will observe the EEG pattern of participants being treated with intramuscular ketamine. The data collected will be used to inform the understanding of brain activity changes in response to ketamine. In addition, genetic markers across participants will be compared, with data on impact of genetic markers and response to ketamine also being analyzed.

For further details see:

Entheon Biomedical gets recruitment underway in EBIQ-101 ketamine study
Stock Information
Company Name: Entheon Biomedical Corp Com
Stock Symbol: ENTBF
Market: OTC
Website: entheonbiomedical.com
Menu
ENTBF ENTBF Quote ENTBF Short ENTBF News ENTBF Articles ENTBF Message Board
Get ENTBF Alerts

News, Short Squeeze, Breakout and More Instantly...